Skip to main content
VTGN logo

VTGN · Vistagen Therapeutics, Inc. · Held by Funds

Track VTGN — free
$0.16 0.00 (-0.85%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Market Cap
$7.27M
Shares
44.38M
Volume · Nov 6 525.18K Avg daily vol (3M) 10.23M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of VTGN by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.40% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.85% 378,044
Index ETFs 3.55% 1,574,200
Active ETFs 0.99% 438,643
Active funds 0.01% 4,985
Unclassified 0.00% 0
All registered funds 5.40% 2,395,872
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding VTGN

9 fund positions
Fund Balance Value % of Fund Open
Showing 1–9 of 9 positions
Key facts CIK 1411685 CUSIP 92840H400 13F (30d) 18 filings 11 filers Visit website Investor relations